Our data suggest that the accumulation of soluble pathogenic tau in AD microvasculature18 and in models of amyloidopathy18 and tauopathy may be explained by the entry of soluble pathogenic tau into brain microvascular endothelial cells. The gene discussed is MAPT; the disease is Alzheimer disease.